December 27, 2022

Insilico Medicine Nominates Preclinical Candidate Targeting KAT6A New York, Dec. 27, 2022 (GLOBE NEWSWIRE) — Insilico Medicine (“Insilico”), a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company, today announced that the company’s drug discovery team has nominated a preclinical candidate targeting KAT6A for ER+/HER2- breast cancer therapy utilizing its end-to-end Pharma.AI platform. The Company has…

Tech Titans Unite: Global Tech Industries Group Inc. and Creatd Inc. in Talks for Epic Merger! New York, NY, Dec. 27, 2022 (GLOBE NEWSWIRE) — (GTII: OTCQB) Global Tech Industries Group, Inc. (“GTII”), www.gtii-us.com, and Creatd, Inc. (CRTD: OTCQB) (“Creatd”), today announced that they have formally begun discussions to explore synergies, including a potential merger….

Did you lose money on investments in Twist Bioscience Corporation? If so, please visit Twist Bioscience Corporation Shareholder Class Action Lawsuit Contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights NEW YORK, Dec. 27, 2022 (GLOBE NEWSWIRE) — Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the…